- Home
- BLFS
as 04-18-2025 1:32pm EST
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.2B | IPO Year: | 1989 |
| Target Price: | $30.57 | AVG Volume (30 days): | 612.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.84 - $29.55 | Next Earning Date: | 05-08-2025 |
| Revenue: | $82,254,000 | Revenue Growth: | 8.44% |
| Revenue Growth (this year): | 20.32% | Revenue Growth (next year): | 19.98% |
Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Apr 9 '25 | Sell | $20.11 | 210 | $4,223.10 | 79,884 | |
| Berard Todd | BLFS | Chief Marketing Officer | Apr 9 '25 | Sell | $20.11 | 324 | $6,515.64 | 135,632 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Apr 9 '25 | Sell | $20.11 | 569 | $11,442.59 | 309,007 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Apr 9 '25 | Sell | $20.11 | 932 | $18,742.52 | 188,310 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Apr 1 '25 | Sell | $22.66 | 5,771 | $130,770.86 | 79,884 | |
| Berard Todd | BLFS | Chief Marketing Officer | Apr 1 '25 | Sell | $22.66 | 8,902 | $201,719.32 | 135,632 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Apr 1 '25 | Sell | $22.66 | 7,869 | $178,311.54 | 195,853 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Apr 1 '25 | Sell | $22.66 | 10,589 | $239,946.74 | 309,007 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Apr 1 '25 | Sell | $22.66 | 25,687 | $582,067.42 | 188,310 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Mar 17 '25 | Sell | $25.44 | 2,695 | $68,560.80 | 79,884 |
Latest BioLife Solutions Inc. News
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Shareholders have faith in loss-making BioLife Solutions (NASDAQ:BLFS) as stock climbs 8.7% in past week, taking five-year gain to 112%
Argus Research
3 days ago
BLFS: Raising target price to $24.00
Zacks
9 days ago
Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?
Argus Research
10 days ago
BLFS: Lowering target price to $22.00
MT Newswires
12 days ago
BioLife Solutions Acquires PanTHERA CryoSolutions to Enhance Biopreservation Portfolio
PR Newswire
12 days ago
BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company
MT Newswires
15 days ago
Biolife Solutions Insider Sold Shares Worth $582,067, According to a Recent SEC Filing
Argus Research
17 days ago
BLFS: Lowering target price to $24.00
Compare BLFS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.